The American College of Physicians issued new guidelines for Type 2 diabetes treatment, which for the first time recommends the use of GLP-1s and another class of diabetes drugs called SGLT-2s ...
A collaborative intervention model involving a clinical pharmacist significantly reduces severe hypoglycemia risk without compromising glycemic control.
Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...
The American College of Lifestyle Medicine has published the first clinical practice guideline focusing primarily on lifestyle interventions for diabetes treatment and potential remission of type 2 ...
The new guideline is the first with clear, practical, and evidence-based strategies on how people with prediabetes or type 2 diabetes can optimize their lifestyle behaviors, sustain lifestyle changes, ...
As a prevalent, complex disease, diabetes presents a challenge to managed care. Strategies to optimize type 2 diabetes care management and treatment outcomes have been evolving over the past several ...
Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United States are currently living with diabetes. That’s 11.6 percent of the ...
Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification. Objectives: To describe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results